Literature DB >> 25203611

Reaction for the synthesis of benzimidazol-2-ones, imidazo[5,4-b]-, and imidazo[4,5-c]pyridin-2-ones via the rearrangement of quinoxalin-2-ones and their aza analogues when exposed to enamines.

Vakhid A Mamedov1, Nataliya A Zhukova, Anastasiya I Zamaletdinova, Tat'yana N Beschastnova, Milyausha S Kadyrova, Il'dar Kh Rizvanov, Victor V Syakaev, Shamil K Latypov.   

Abstract

A synthetically useful protocol has been developed for the preparation of highly functionalized N-pyrrolylbenzimidazol-2-ones. The reaction of variously substituted 3-aroyl- and 3-alkanoylquinoxalin-2(1H)-ones with commercially available enamines in acetic acid results in a rapid rearrangement and formation of N-pyrrolylbenzimidazol-2-ones in modest to excellent yields. The key step of the rearrangement involves the novel ring contraction of 3-aroyl- and 3-alkanoylquinoxalin-2(1H)-ones with enamines. In this case, the atom of carbon which is displaced from the pyrazine ring of quinoxalin-2(1H)-one becomes the fourth carbon atom of the newly formed pyrrole ring. The method is applicable for the aza analogues of quinoxalin-2(1H)-ones.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25203611     DOI: 10.1021/jo501526a

Source DB:  PubMed          Journal:  J Org Chem        ISSN: 0022-3263            Impact factor:   4.354


  2 in total

1.  Visible-light-induced C(sp3)-H activation for a C-C bond forming reaction of 3,4-dihydroquinoxalin-2(1H)-one with nucleophiles using oxygen with a photoredox catalyst or under catalyst-free conditions.

Authors:  Pavan Sudheer Akula; Bor-Cherng Hong; Gene-Hsiang Lee
Journal:  RSC Adv       Date:  2018-05-29       Impact factor: 4.036

2.  Route to Benzimidazol-2-ones via Decarbonylative Ring Contraction of Quinoxalinediones: Application to the Synthesis of Flibanserin, A Drug for Treating Hypoactive Sexual Desire Disorder in Women and Marine Natural Product Hunanamycin Analogue.

Authors:  Rahul D Shingare; Akshay S Kulkarni; Revannath L Sutar; D Srinivasa Reddy
Journal:  ACS Omega       Date:  2017-08-29
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.